25 of the Best Infectious Disease Doctors Near Me in Bowie, MD

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.

John Baddley is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Baddley is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia. Dr. Baddley is board certified in American Board Of Internal Medicine.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is highly rated in 12 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection. Dr. Quinn is board certified in American Board Of Internal Medicine.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Avery is board certified in American Board Of Internal Medicine.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome. Dr. Blankson is board certified in American Board Of Internal Medicine.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is highly rated in 6 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and COVID-19. Dr. Kirk is board certified in American Board Of Internal Medicine.

Jeanne Sheffield is an Infectious Disease specialist and a Neonatologist practicing medicine in Baltimore, Maryland. Dr. Sheffield is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Congenital Syphilis, Placenta Previa, Zika Virus Disease, Achalasia Microcephaly Syndrome, and Hysterectomy. Dr. Sheffield is board certified in American Board Of Obstetrics And Gynecology.

Dr. Gregory M. Lucas is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS and infectious disease. Dr. Lucas received his undergraduate degree from the University of Notre Dame. He earned his M.D. from Duke University School of Medicine and his Ph.D. from Johns Hopkins. He completed his residency and performed a fellowship in infectious diseases at Johns Hopkins. He serves on the faculties of the Center for AIDS Research, where he is co-director of the Substance Use Scientific Working Group; the Center for Substance Abuse Treatment and Research; the Center for Adolescent Health; and the Heart and Vascular Institute. Dr. Lucas is highly rated in 6 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Myelitis, and AIDS Dementia Complex. Dr. Lucas is board certified in American Board Of Internal Medicine.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy. Dr. Durand is board certified in American Board Of Internal Medicine.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Sulkowski is board certified in American Board Of Internal Medicine.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is highly rated in 4 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Gonorrhea, Chlamydia, and Sepsis. Dr. Crowell is board certified in American Board Of Internal Medicine.

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis. Dr. Falade is board certified in American Board Of Internal Medicine.

Dr. Christopher Hoffmann's primary appointment is in the Department of Medicine, Division of Infectious Diseases. His areas of clinical expertise include HIV/AIDS and infectious diseases. Dr. Hoffmann earned his M.D. and M.P.H. from Oregon Health and Sciences University. He completed his residency at Johns Hopkins and performed a fellowship in infectious diseases at Johns Hopkins. His research interests include care delivery and care utilization, in low- and middle-income settings (mostly Africa), and clinical management of HIV and TB. Dr. Hoffmann is a member of several professional organizations, including the American College of Physicians and the Infectious Diseases Society of America. Dr. Hoffmann is highly rated in 2 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis, Myelitis, and AIDS Dysmorphic Syndrome. Dr. Hoffmann is board certified in American Board Of Internal Medicine.

Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever. Dr. Durbin is board certified in American Board Of Internal Medicine.

Dr. Richard Moore is recognized for mentorship of medical students, residents, fellows, and junior faculty in HIV/AIDS Research. Winner of the David M. Levine Mentorship Awards in the General Internal Medicine Department, he is an expert in pharmacoepidemiology, clinical epidemiology, and health services research. Now serving as the Director of the Moore Clinic for HIV Care, which began in 1984, he has influenced the careers of young scholars not only in General Internal Medicine, but also in the Infectious Disease Division. His colleagues and mentees praise him for his accessibility, his patience, his scientific candor, his instinct for compelling research, his insight, and his abilities as a teacher and editor. Dr. Moore has authored 129 original manuscripts, 24 chapters, reviews and letters. For his medical degree he attended Vanderbilt University School of Medicine where he also completed his Internship and Residency in the Department of Medicine. A fellowship, completed at Johns Hopkins University, Department of Medicine, Division of Internal Medicine, was followed by a Masters of Health Sciences at the Johns Hopkins University, Bloomberg School of Public Health, Department of Epidemiology. Dr. Moore is highly rated in 13 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Sepsis, Hepatitis C, Hepatitis, and Gastrostomy. Dr. Moore is board certified in American Board Of Internal Medicine.

Kathleen Neuzil is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Neuzil is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.

Dr. Matthew Hamill is interested in all aspects of Sexually Transmitted Infections (STI) and HIV. This includes, prevention, treatment, and retention in care. His research focuses on rapid, Point-of-Care diagnostics for STI in low-income settings. He provides patient-focused treatment for those with, or at risk of, STI and HIV (including Pre Exposure Prophylaxis/PrEP). He has expertise in providing care for LGBTQ+ communities. Dr. Hamill is a UK-trained physician, he received his medical degree in 1998 (MB ChB), trained in internal medicine followed by sexual health/HIV training in London, UK. He spent 3 years conducting research in Soweto, South Africa. In addition to his primary affiliation with Johns Hopkins School of Medicine, he is also affiliated with the Department of Population, Family, and Reproductive Health at the Bloomberg School of Public Health. Dr. Hamill is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Syphilis, Gonorrhea, Urethritis, and Neurosyphilis.

Dr. Gloria K. Aggrey graduated from Case Western Reserve University School of Medicine in 2004. She completed a residency in Internal Medicine in the Rhode Island Hospital/Miriam Hospital Program at Brown University in 2007. She then completed a fellowship in Infectious Diseases at Boston University in 2009. Dr. Aggrey is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sepsis, Strep Throat, Pneumonia, and Asymptomatic Bacteriuria. Dr. Aggrey is board certified in American Board Of Internal Medicine.

Khalil Ghanem's, M.D., Ph.D., research interests include sexually transmitted infections and the vaginal microbiome. In 2008, he received his Ph.D. degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Ghanem is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Neurosyphilis, Syphilis, Gonorrhea, and Chlamydia. Dr. Ghanem is board certified in American Board Of Internal Medicine.

Amita Gupta is an Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Gupta is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gupta is board certified in American Board Of Internal Medicine.

Dr. Joyce Leitch Jones is a faculty member at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious diseases. Dr. Jones earned her M.D. at the University of Maryland School of Medicine. She completed her residency at Columbia University Medical Center and performed a fellowship in epidemiology at Weill Cornell Medical College. Dr. Jones is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Jones is board certified in American Board Of Internal Medicine.

Dr. Petros Karakousis is a Professor of Medicine at the Johns Hopkins University School of Medicine. He has joint appointments in Molecular Microbiology & Immunology and International Health at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include infectious diseases and tuberculosis. Dr. Karakousis received his undergraduate degree in 1994 from the Johns Hopkins University and his medical degree in 1998 from Washington University School of Medicine in St. Louis. He completed residency training in internal medicine in 2001 at the Hospital of the University of Pennsylvania. After completing fellowship training in infectious diseases at Johns Hopkins, he joined the Department of Medicine faculty in 2005. His research interests include tuberculosis pathogenesis, Mycobacterium tuberculosis persistence and antibiotic tolerance, host-pathogen interactions and host-directed therapies. Dr. Karakousis was named a Fellow of the Infectious Diseases Society of America in 2010, and was elected to the American Society for Clinical Investigation in 2021. He has held numerous leadership positions, including in the Working Group on New TB Drugs of the Stop TB Partnership. He has served on the editorial board of various scientific journals and on numerous NIH study sections, and as a peer reviewer for many international government and private funding agencies. Dr. Karakousis is highly rated in 5 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Karakousis is board certified in American Board Of Internal Medicine.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B. Dr. Balagopal is board certified in American Board Of Internal Medicine.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS. Dr. Moon is board certified in American Board Of Internal Medicine.